Abstract: A method of improving the resolution of images from medical imaging devices by removing blurring due to movement of a patient during a scan. The method uses tracking algorithms to extract movement data from a video image of the patient and uses the movement data to correct the scanner date and remove the effects of movement. Also disclosed is a calibration process to calibrate the movement data to the scanner data.
Type:
Application
Filed:
July 3, 2013
Publication date:
May 21, 2015
Applicant:
The State of Queensland Acting Through Its Department of Health
Abstract: A method for determining whether a human individual is or has been infected with Neisseria gonorrhoeae, is provided. The method detects a Neisseria gonorrhoeae, porA nucleic acid fragment obtained from a biological sample. The method includes subjecting the biological sample to nucleic acid sequence amplification using primers having respective nucleotide sequences according to SEQ ID NO:1 and SEQ ID NO:2, to thereby produce a porA Neisseria gonorrhoeae, amplification product. The amplification product is detected by fluorescence resonance energy transfer using oligonucleotides having respective nucleotide sequences according to SEQ ID NO:3 which has a donor fluorophore and SEQ ID NO:4, which has an acceptor fluorophore.
Type:
Application
Filed:
June 23, 2011
Publication date:
November 24, 2011
Applicant:
The State of Queensland Acting Through Its Department of Health
Abstract: A method for determining whether a human individual is or has been infected with Neisseria gonorrhoeae, is provided. The method detects a Neisseria gonorrhoeae, porA nucleic acid fragment obtained from a biological sample. The method includes subjecting the biological sample to nucleic acid sequence amplification using primers having respective nucleotide sequences according to SEQ ID NO:1 and SEQ ID NO:2, to thereby produce a porA Neisseria gonorrhoeae, amplification product. The amplification product is detected by fluorescence resonance energy transfer using oligonucleotides having respective nucleotide sequences according to SEQ ID NO:3 which has a donor fluorophore and SEQ ID NO:4, which has an acceptor fluorophore.
Type:
Grant
Filed:
April 6, 2005
Date of Patent:
August 16, 2011
Assignee:
The State of Queensland Acting Through Its Department of Health
Abstract: A method for determining whether a human individual is or has been infected with Neisseria gonorrhoeae, is provided. The method detects a Neisseria gonorrhoeae, porA nucleic acid fragment obtained from a biological sample. The method includes subjecting the biological sample to nucleic acid sequence amplification using primers having respective nucleotide sequences according to SEQ ID NO:1 and SEQ ID NO:2, to thereby produce a porA Neisseria gonorrhoeae, amplification product. The amplification product is detected by fluorescence resonance energy transfer using oligonucleotides having respective nucleotide sequences according to SEQ ID NO:3 which has a donor fluorophore and SEQ ID NO:4, which has an acceptor fluorophore.
Type:
Application
Filed:
April 6, 2005
Publication date:
May 21, 2009
Applicant:
The State of Queensland Acting Through Its Department of Health